Clinical, Laboratory, And Immunological Changes In The Urinary System In Children With Juvenile Idiopathic Arthritis
Keywords:
Juvenile idiopathic arthritis, urinary system, kidneysAbstract
Juvenile idiopathic arthritis (JIA) is a chronic inflammatory disease of the joints in children, characterized by autoimmune damage to connective tissue and systemic manifestations. Among extra-articular lesions, particular importance is attached to the involvement of the urinary system, which significantly affects the course, prognosis, and treatment strategy of the disease.
Objective: To study the clinical and immunological changes in the urinary system in children with juvenile idiopathic arthritis.
Materials and Methods: A total of 80 patients aged 4–17 years were examined. All patients underwent clinical, laboratory, and immunological studies.
Results: Urinary system involvement was detected in 66 (82.5%) children, manifested by leukocyturia (79%), proteinuria (52%), hematuria (35%), and the presence of salts in the urine (32%). Serum IL-6 levels were elevated 5.8-fold, particularly in polyarticular and systemic forms of the disease.
References
Alekseeva, E.I., Denisova, R.V., Valieva, S.I. et al. (2017). Cytokines in juvenile idiopathic arthritis: modern concepts of immunopathogenesis. Pediatric Pharmacology, 14 (3), 180–190.
Alekseeva, E.I., Denisova, R.V., Valieva, S.I. et al. (2018). Juvenile idiopathic arthritis: clinical and laboratory characteristics and principles of therapy. Pediatric Pharmacology, 15(2), 95–102.
Alekseeva, E.I., Denisova, R.V., Valieva, S.I. et al. (2015). Juvenile idiopathic arthritis: course features and outcomes. Pediatrics Journal, 94(6), 45–52.
Avcin, T., Cimaz, R., & Frosch, M. (2019). Pathogenesis and classification of juvenile idiopathic arthritis. Nature Reviews Rheumatology, 15, 457–472.
Berkun, Y., & Padeh, S. (2010). Environmental factors and the development of juvenile idiopathic arthritis. Autoimmunity Reviews, 9, 319–323.
Brunner, H.I., & Lovell, D.J. (2019). Advances in the understanding and treatment of juvenile idiopathic arthritis. Current Opinion in Rheumatology, 31(5), 395–402.
Chudakova, L.G., & Kurilo, A.N. (2016). Functional state of kidneys in children with juvenile idiopathic arthritis. Russian Bulletin of Perinatology and Pediatrics, 61(5), 82–88.
Cimaz, R., & Cantarini, L. (2020). Autoinflammatory diseases and juvenile idiopathic arthritis: links and differences. International Journal of Molecular Sciences, 21(22), 8534.
Denisova, R.V., Alekseeva, E.I., & Valieva, S.I. (2019). Cytokine profile in juvenile idiopathic arthritis and correlation with disease activity. Modern Pediatrics, 18(4), 23–28.
Dubko, M.F., & Klimanskaya, E.V. (2018). Renal involvement in rheumatic diseases in children. Nephrology and Dialysis, 20(3), 47–52.
Elkon, K.B., & Stone, J.H. (2018). Renal disease in rheumatology. New England Journal of Medicine, 379, 2541–2552.
Frosch, M., & Roth, J. (2008). Role of interleukin-6 in the pathogenesis of systemic juvenile idiopathic arthritis and the therapeutic approach with tocilizumab. Current Opinion in Rheumatology, 20(5), 579–584.
Guseva, N.G., & Dubko, M.F. (2017). Pathogenesis of renal involvement in rheumatoid arthritis and juvenile idiopathic arthritis. Therapeutic Archive, 89(8), 65–70.
Guzikova, M.V., & Kuznetsova, I.V. (2019). The features of urinary system pathology in children with rheumatic diseases. Clinical Nephrology, 18(2), 33–39.
Hinks, A., Bowes, J., & Thomson, W. (2019). Genetic susceptibility to juvenile idiopathic arthritis. Rheumatology, 58(2), 275–283.
Kamyshova, E.V., & Koneva, N.A. (2018). Urinary system pathology in children with rheumatoid arthritis. Modern Pediatrics, 17(1), 52–57.
Kawashima, M., & Ogata, A. (2019). The role of IL-6 in autoimmune diseases. Clinical and Experimental Rheumatology, 37(Suppl. 119), 4–10.
Kiselyova, N.G., & Abramova, L.M. (2016). Amyloidosis in children with chronic rheumatic diseases. Clinical Medicine, 94(3), 62–66.
Kuzmina, N.S., & Guseva, N.G. (2015). Renal changes in rheumatoid arthritis. Therapeutic Archive, 87(5), 60–65.
Petty, R.E., Southwood, T.R., Manners, P. et al. (2004). International League of Associations for Rheumatology (ILAR) classification of juvenile idiopathic arthritis: second revision. Journal of Rheumatology, 31(2), 390–392.
Ravelli, A., Martini, A. (2007). Juvenile idiopathic arthritis. Lancet, 369, 767–778.
Sukhareva, E.Yu., & Alekseeva, E.I. (2018). Systemic forms of juvenile idiopathic arthritis in children: clinical course and therapy. Pediatric Pharmacology, 15(6), 512–519.
Tarp, S., & Ammitzbøll-Danielsen, M. (2018). Cytokine and chemokine patterns in juvenile idiopathic arthritis: a systematic review. Rheumatology International, 38, 1571–1580.
Tugal-Tutkun, I., & Quartier, P. (2019). Systemic juvenile idiopathic arthritis and IL-6: clinical implications and targeted therapy. Pediatric Rheumatology, 17, 45–52.
Vastert, S.J., & de Jager, W. (2014). Cytokines in the pathogenesis of juvenile idiopathic arthritis: current insights. Pediatric Rheumatology, 12, 12–25.
Wallace, C.A., Ruperto, N., & Giannini, E.H. (2017). Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. Journal of Rheumatology, 31, 2290–2294.
Wulffraat, N.M., & Wedderburn, L.R. (2019). Pathogenesis and treatment of juvenile idiopathic arthritis. Nature Reviews Rheumatology, 15, 363–376.
Yershov, M.I., & Dvornikova, I.V. (2019). Renal manifestations of rheumatic diseases in children. Pediatrics Journal, 98(4), 39–44.
Zink, J., & Hirschfeld, S. (2017). Amyloidosis in pediatric rheumatic diseases. Autoimmunity Reviews,16, 729–737.
Zyryanova, I.V., & Baranov, A.A. (2015). Modern concepts of the immunopathogenesis of juvenile idiopathic arthritis. Pediatric Pharmacology, 12(5), 22–29.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Israilova N.A., Yusupova G.A., Azimova R.A.
This work is licensed under a Creative Commons Attribution 4.0 International License.
